Literature DB >> 16867866

Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.

Paola de Candia1, Muzaffar Akram, Robert Benezra, Edi Brogi.   

Abstract

Id (inhibitor of DNA binding) 4 is a member of the Id family of proteins (Id1-Id4), which function as dominant-negative regulators of basic helix-loop-helix transcription factors. Id factors are involved in numerous cell processes, including cell proliferation, differentiation, and tumorigenesis. We assessed the expression of Id4 messenger RNA (mRNA) in invasive mammary carcinoma from 31 patients, as well as in 21 cases of ductal carcinoma in situ, in 9 lymph node metastases, and in the morphologically normal epithelium adjacent to the carcinoma from the same subjects. In addition, we evaluated Id4 mRNA in atypical ductal hyperplasia from 5 other women and in normal breast tissue from yet another 5 women with no history of breast malignancy or atypia. The distribution of Id4 signal was assessed in relation to that of estrogen receptor (ER) in all samples and correlated with the Her-2 status of the carcinomas. Id4 mRNA was present in the normal ER-negative mammary epithelium in all cases; in contrast, the ER-positive cells present in the normal breast were Id4 negative. Id4 mRNA was not detected in atypical ductal hyperplasia, in 22 of the 23 cases of ductal carcinoma in situ, and in 27 of the 31 invasive carcinomas (P = .0008), all of which were ER positive. Conversely, 3 of the 31 invasive carcinomas were Id4 positive and ER negative. Only 1 ER-positive invasive carcinoma showed focal reactivity for Id4. The expression of Id4 in metastatic carcinoma paralleled that of the primary tumor. No correlation was apparent between Id4 and Her-2. Our data show that Id4 is constitutively expressed in the normal human mammary epithelium but is suppressed in ER-positive breast carcinomas and preneoplastic lesions. In contrast, ER-negative carcinomas appear to be Id4 positive. These results support a possible role of Id4 as a tumor suppressor factor in the human breast and suggest that the expression of Id4 in the mammary ductal epithelium may be regulated by estrogen. Further investigations are required to define the functions of Id4 in the human normal breast and in mammary neoplasia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16867866     DOI: 10.1016/j.humpath.2006.03.004

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

1.  Hypomethylation of DNA-binding inhibitor 4 serves as a potential biomarker in distinguishing acquired tamoxifen-refractory breast cancer.

Authors:  Yonghui Zhang; Bin Zhang; Jing Fang; Xuchen Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  ID4 regulates mammary gland development by suppressing p38MAPK activity.

Authors:  Jie Dong; Shixia Huang; Marian Caikovski; Shaoquan Ji; Amanda McGrath; Myra G Custorio; Chad J Creighton; Paul Maliakkal; Ekaterina Bogoslovskaia; Zhijun Du; Xiaomei Zhang; Michael T Lewis; Fred Sablitzky; Cathrin Brisken; Yi Li
Journal:  Development       Date:  2011-12       Impact factor: 6.868

3.  Transcriptional response of the murine mammary gland to acute progesterone exposure.

Authors:  Rodrigo Fernandez-Valdivia; Atish Mukherjee; Chad J Creighton; Adam C Buser; Francesco J DeMayo; Dean P Edwards; John P Lydon
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

4.  [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].

Authors:  E Noetzel; J Veeck; F Horn; A Hartmann; R Knüchel; E Dahl
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

5.  Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.

Authors:  Pankaj Sharma; Swathi Chinaranagari; Jaideep Chaudhary
Journal:  Biochimie       Date:  2015-03-13       Impact factor: 4.079

Review 6.  Inhibitor of differentiation 4 (ID4): From development to cancer.

Authors:  Divya Patel; Derrick J Morton; Jason Carey; Mathew C Havrda; Jaideep Chaudhary
Journal:  Biochim Biophys Acta       Date:  2014-12-12

7.  The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis.

Authors:  Giulia Fontemaggi; Stefania Dell'Orso; Daniela Trisciuoglio; Tal Shay; Elisa Melucci; Francesco Fazi; Irene Terrenato; Marcella Mottolese; Paola Muti; Eytan Domany; Donatella Del Bufalo; Sabrina Strano; Giovanni Blandino
Journal:  Nat Struct Mol Biol       Date:  2009-09-27       Impact factor: 15.369

Review 8.  E Proteins and ID Proteins: Helix-Loop-Helix Partners in Development and Disease.

Authors:  Lan-Hsin Wang; Nicholas E Baker
Journal:  Dev Cell       Date:  2015-11-09       Impact factor: 12.270

9.  A resampling-based meta-analysis for detection of differential gene expression in breast cancer.

Authors:  Bala Gur-Dedeoglu; Ozlen Konu; Serkan Kir; Ahmet Rasit Ozturk; Betul Bozkurt; Gulusan Ergul; Isik G Yulug
Journal:  BMC Cancer       Date:  2008-12-30       Impact factor: 4.430

10.  Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.

Authors:  Erik Noetzel; Jürgen Veeck; Dieter Niederacher; Oliver Galm; Felicitas Horn; Arndt Hartmann; Ruth Knüchel; Edgar Dahl
Journal:  BMC Cancer       Date:  2008-05-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.